Neurontin (Gabapentin)

Gabapentin binds to the α2δ subunit of voltage‑gated calcium channels in the central nervous system. This binding limits calcium entry into neurons, decreasing the release of excitatory neurotransmitters like glutamate and substance P, which reduces neuronal hyper‑excitability and alleviates pain and seizure activity.

The specific dose of Neurontin is determined by the prescribing clinician based on the individual’s medical condition, age, renal function and response to therapy. Dosage regimens can vary widely, and any adjustments should be made under professional medical supervision.

Safety data for gabapentin in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should discuss individual risks and consider alternative therapies when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Neurontin. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Gabapentin differs from many traditional anticonvulsants because it does not bind to GABA receptors. Instead, it modulates calcium channels, offering a favorable side‑effect profile for neuropathic pain. Compared with drugs like carbamazepine or phenytoin, gabapentin is often better tolerated but may be less potent for certain seizure types.

Neurontin should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Neurontin is taken orally, usually in tablet or capsule form, with or without food as directed by a healthcare professional. The medication should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.

Serious risks include severe skin reactions such as Stevens‑Johnson syndrome, suicidal thoughts or behavior, respiratory depression when combined with other CNS depressants, and rare blood disorders. Patients should seek immediate medical attention if they notice rash, mood changes, difficulty breathing or unusual bleeding.

Neurontin is contraindicated in individuals with known hypersensitivity to gabapentin or any of its excipients. Caution is advised for patients with severe renal impairment, uncontrolled depression, or those taking multiple CNS depressants. Pregnant or breastfeeding women should only use it after thorough risk‑benefit evaluation by their physician.